← Eichor
Study identifier: NCT04667078 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts

Condition: Acute Ischemia  ·  Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

PhasePhase 3
Planned participants368
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The main objective is to evaluate the efficacy of IV administration of the P2Y12 inhibitor (cangrelor) in addition to mecanich thrombectomy and WMD versus mecanich thrombectomy and WMD alone on the functional prognosis at 3 months, in patients with acute ischemic stroke eligible for mecanich thrombectomy on the basis of infusion imaging between 0 and 24 hours after the onset of symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Mikael Pr MAZIGHI, Pr  ·  01 48 03 65 65  ·  mmazighi@for.paris

Amélie YAVCHITZ, MD, PhD  ·  01 48 03 64 54  ·  ayavchitz@for.paris

Always discuss trial participation with your own doctor first.

Locations (13)

CHU de BesançonBesançon, FranceRecruiting
Hôpital Pellegrin (CHU de Bordeaux)Bordeaux, FranceRecruiting
Hospices civils de Lyon, Hôpital Pierre WertheimerBron, FranceRecruiting
Hôpital Salengro (CHU Lille)Lille, FranceRecruiting
Hôpital Dupuytren (CHU Limoges)Limoges, FranceRecruiting
CHU La TimoneMarseille, FranceRecruiting
Hôpital Central (CHU de Nancy)Nancy, FranceRecruiting
Hôpital Lariboisière AP-HPParis, FranceRecruiting
Hôpital Pitié-Salpêtrière AP-HPParis, FranceRecruiting
Hôpital Fondation A de RothschildParis, FranceRecruiting
CHU de StrasbourgStrasbourg, FranceRecruiting
Hôpital FochSuresnes, FranceRecruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04667078